European Patent Bulletin 2012/09 - European Patent Office
19.12.2012 • Views
Share Embed Flag

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

European Patent Bulletin 2012/09 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(2)<br />

(74) Carpmaels & Ransford, One Southampton<br />

Row, London WC1B 5HA, GB<br />

(62) 05745707.9 / 1 750 696<br />

A61K 31/337 → (51) A61K 9/51<br />

A61K 31/343 → (51) A61K 31/335<br />

A61K 31/343 → (51) C07C 235/46<br />

A61K 31/351 → (51) C07C 235/46<br />

A61K 31/352 → (51) A61P 35/00<br />

A61K 31/353 → (51) A61K 31/335<br />

A61K 31/353 → (51) A61K 31/513<br />

A61K 31/353 → (51) A61K 45/06<br />

A61K 31/353 → (51) A61P 35/00<br />

A61K 31/357 → (51) C07C 235/46<br />

A61K 31/36 → (51) C07C 235/46<br />

A61K 31/381 → (51) C07C 235/46<br />

A61K 31/382 → (51) C07D 495/04<br />

A61K 31/40 → (51) A61K 9/00<br />

A61K 31/40 → (51) C07C 43/225<br />

A61K 31/40 → (51) C07C 235/46<br />

A61K 31/4015 → (51) C07C 43/225<br />

A61K 31/402 → (51) C07C 235/46<br />

A61K 31/4025 → (51) C12P 17/16<br />

A61K 31/403 → (51) C07D 2<strong>09</strong>/14<br />

A61K 31/4035 → (51) C07C 235/46<br />

A61K 31/404 → (51) A61P 35/00<br />

A61K 31/404 → (51) C07C 235/46<br />

A61K 31/405 → (51) C07D 2<strong>09</strong>/14<br />

A61K 31/41 → (51) C07C 235/46<br />

A61K 31/415 → (51) C07C 235/46<br />

A61K 31/416 → (51) A61K 31/335<br />

A61K 31/421 → (51) C07C 235/46<br />

A61K 31/427 → (51) C07D 277/20<br />

A61K 31/4365 → (51) C07D 495/04<br />

A61K 31/437 → (51) A61K 31/192<br />

(51) A61K 31/44 (11) 2 422 782 A1<br />

(25) En (26) En<br />

(21) 11168901.4 (22) 11.04.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR LV MK YU<br />

(30) <strong>09</strong>.04.2004 US 560894<br />

08.04.2005 US 102559<br />

(54) Verfahren zur Verwendung von Aminopyrin-Zusammensetzungen<br />

mit verzögerter<br />

Freisetzung<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

Methods of Using Sustained Release<br />

Aminopyridine Compositions<br />

Utilisation de compositions d'aminopyridine<br />

à libération soutenue<br />

(71) Acorda Therapeutics, Inc., 15 Skyline Drive,<br />

Hawthorne NY 10531, US<br />

(72) Blight, Andrew R., Mahopac, NY 10541, US<br />

Cohen, Ron, Irvington, NY 10533, US<br />

(74) Carpmaels & Ransford, One Southampton<br />

Row, London WC1B 5HA, GB<br />

(62) 05732613.4 / 1 732 548<br />

A61K 31/44 → (51) A61K 31/513<br />

A61K 31/44 → (51) C07D 213/65<br />

A61K 31/4406 → (51) A61K 45/00<br />

A61K 31/4412 → (51) A61K 31/192<br />

A61K 31/4418 → (51) C07D 213/65<br />

A61K 31/443 → (51) C07D 213/65<br />

A61K 31/4433 → (51) C07D 213/65<br />

A61K 31/4439 → (51) C07D 213/65<br />

A61K 31/454 → (51) C07D 2<strong>09</strong>/14<br />

A61K 31/454 → (51) C07D 277/20<br />

A61K 31/47<strong>09</strong> → (51) C07D 277/20<br />

A61K 31/47<strong>09</strong> → (51) C07D 401/12<br />

A61K 31/472 → (51) C07D 217/22<br />

A61K 31/4725 → (51) C07D 217/22<br />

(51) A61K 31/496 (11) 2 422 783 A1<br />

A61K 9/20 A61K 47/10<br />

A61K 47/26 A61K 47/38<br />

C07D 417/12<br />

(25) En (26) En<br />

(21) 11181100.6 (22) 26.05.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT<br />

RO SE SI SK TR<br />

(30) 26.05.2005 JP 2005153508<br />

(54) Pharmazeutische Zusammensetzung<br />

Pharmaceutical Composition<br />

Composition pharmaceutique<br />

(71) Dainippon Sumitomo Pharma Co., Ltd., 6-8,<br />

Dosho-machi 2-chome Chuo-ku Osaka-shi,<br />

Osaka 541-8524, JP<br />

(72) Fujihara, Kazuyuki, Ibaraki-shi, Osaka 567-<br />

0878, JP<br />

(74) Vossius & Partner, Siebertstrasse 4, 81675<br />

München, DE<br />

(62) 06746900.7 / 1 884 242<br />

A61K 31/496 → (51) A61K 9/12<br />

A61K 31/496 → (51) C07D 277/20<br />

(51) A61K 31/513 (11) 2 422 784 A1<br />

A61K 31/216 A61P 35/00<br />

A61K 31/353<br />

(25) En (26) En<br />

(21) 10173256.8 (22) 18.08.2010<br />

(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR<br />

GB GR HR HU IE IS IT LI LT LU LV MC MK<br />

MT NL NO PL PT RO SE SI SK SM TR<br />

BA ME RS<br />

(54) Zusammensetzung aus TEGAFUR und<br />

Kaffeinsäurephenethyl-Ester (CAPE) und<br />

entweder Catechin, Kaempherol, Myrecetin<br />

oder Luteolin zur Potenzierung der<br />

203<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>09</strong>/<strong>2012</strong>) 29.02.<strong>2012</strong><br />

Antitumor-Wirkung und zur Behandlung<br />

von Tumoren<br />

Composition of TEGAFUR, caffeic acid<br />

phenethyl ester (CAPE) and either<br />

catechin, kaempherol, myricetin or luteolin<br />

for potentiating antitumour effect and for<br />

treating tumours<br />

Composition de TEGAFUR et d'ester<br />

phénéthylique de l'acide caféique (CAPE)<br />

en combinaison avec de catéchine, de<br />

caempherol, de myricetine ou de luteoline<br />

pour augmenter l'effet anti-tumeur et pour<br />

traiter des tumeurs<br />

(71) Grindeks, a joint stock company, 53,<br />

Krustpils Street, 1057 Riga, LV<br />

(72) Kalvins, Ivars, 1006 Riga, LV<br />

Stonans, Ilmars, 1057 Riga, LV<br />

Sestakova, Irina, 1006 Riga, LV<br />

Domracova, Ilona, 1006 Riga, LV<br />

Jascenko, Elina, 1006 Riga, LV<br />

Bridane, Veronika, 1006 Riga, LV<br />

Kanepe, Iveta, 1006 Riga, LV<br />

(51) A61K 31/513 (11) 2 422 785 A1<br />

A61K 31/44 A61P 35/00<br />

A61P 43/00 C07D 405/02<br />

(25) Ja (26) En<br />

(21) 10767135.6 (22) 22.04.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) JP 2010/057176 22.04.2010<br />

(87) WO 2010/123078 2010/43 28.10.2010<br />

(30) 22.04.20<strong>09</strong> JP 20<strong>09</strong>104189<br />

(54) VERFAHREN ZUR VORHERSAGE DER<br />

WIRKSAMKEIT VON CHEMOTHERAPIE<br />

BEI NIERENZELLKARZINOM<br />

METHOD FOR PREDICTING THERA-<br />

PEUTIC EFFECT OF CHEMOTHERAPY ON<br />

RENAL CELL CANCER<br />

PROCÉDÉ DE PRÉDICTION DE L'EFFET<br />

THÉRAPEUTIQUE D'UNE CHIMIOTHÉ-<br />

RAPIE SUR UN CANCER À CELLULES<br />

RÉNALES<br />

(71) Taiho Pharmaceutical Co., Ltd., 1-27,<br />

Kandanishiki-cho, Chiyoda-ku, Tokyo 101-<br />

8444, JP<br />

(72) AKAZA, Hideyuki, Tokyo 160-0023, JP<br />

NAITO, Seiji, Fukuoka-shi Fukuoka 810-<br />

0053, JP<br />

OKA, Toshinori, Tokushima-shi Tokushima<br />

771-0194, JP<br />

(74) Vossius & Partner, Siebertstrasse 4, 81675<br />

München, DE<br />

A61K 31/513 → (51) A61K 45/06<br />

A61K 31/513 → (51) A61P 35/00<br />

A61K 31/513 → (51) C07D 401/04<br />

A61K 31/525 → (51) A61K 9/20<br />

A61K 31/53 → (51) A61K 31/05<br />

A61K 31/536 → (51) C07D 265/26<br />

A61K 31/5377 → (51) C07D 277/20<br />

A61K 31/5377 → (51) C07D 401/04<br />

(51) A61K 31/538 (11) 2 422 786 A1<br />

A61P 11/06<br />

(25) De (26) De<br />

(21) 11187038.2 (22) 18.04.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO<br />

SE SI SK TR<br />

(30) 07.02.2005 EP 05002496<br />

22.04.2004 DE 102004019540

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!